| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |